stronger warning about potential hepatotoxicity in patients taking Duract (bromfenac)

The FDA is requiring a stronger warning about potential hepatotoxicity in patients taking Duract (bromfenac). ...

Exclusive Subscriber Content

  • Best in class medication learning
  • Concise recommendations
  • Hundreds of practical resources

Subscribe Now Learn More

Login to access this content.

Login